SCHEMBL4602875

SCHEMBL4602875

CCCCCS(=O)(=O)NC(=O)CC

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.40
PTPN1 P18031 1/20 0.39
CES2 O00748 2/20 0.38
CES1 P23141 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72463 0.85 MEN1 (0.36)
SCHEMBL14166663 0.84 HSP90AA1 (0.48) FAAH
SCHEMBL4732400 0.84 HSP90AA1 (0.53) FAAHCES2CES1
SCHEMBL4732709 0.84 HSP90AA1 (0.53) FAAHCES2CES1
SCHEMBL4731984 0.84 HSP90AA1 (0.53) FAAHCES2CES1
SCHEMBL8091952 0.83 FAAH (0.43) FAAHPTPN1CES2
SCHEMBL26244153 0.82 APP (0.41)
SCHEMBL3220018 0.81 PTPN1 (0.43) FAAHPTPN1CES2
SCHEMBL13113281 0.81 FAAH (0.41) FAAHPTPN1CES2CES1
SCHEMBL8292803 0.80 HSP90AA1 (0.53) FAAHPTPN1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed